je.st
news
Orexo sells Abstral in the United States to Galena Biopharma, Inc.
2013-03-18 12:20:48| Biotech - Topix.net
"With an agreement in place for Abstral, we have further strengthened our financial capacity to ensure the optimal launch of Zubsolv in the United States, which will be the primary focus for Orexo in 2013" Orexo AB today announced that it sold AbstralA Sublingual Tablets in the United States to Galena Biopharma, Inc.
Tags: inc
united
states
united states
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||